Abstract:Hyperlipidemia is a major independent risk factor for atherosclerosis. Seeking natural compounds in medicinal plants capable of reducing blood fat and studying their mechanisms of action has been the focus of research in recent years. The aim of the present study was to analyze the mechanisms of apigenin in regulating cholesterol metabolism and protecting blood vessels, and to provide a theoretical basis for the clinical application of apigenin. The mouse model of hyperlipidemia was established to verify the efficacy of apigenin in improving hyperlipidemia and to observe the mechanism of action of apigenin in reducing cholesterol content. In vitro cell experiments were conducted to evaluate the role of apigenin in mediating reverse cholesterol transport. Additionally, H2O2-injured human umbilical venous endothelial cells (EA.hy926 cells) were used for further study on the roles of apigenin in resisting oxidization and protecting vascular endothelial cells. Apigenin significantly regulated blood fat, reduced animal weight, and reduced total cholesterol (P=0.024), triglyceride (P=0.031) and low-density lipoprotein cholesterol (P=0.014) in the serum of the high-fat diet mice. Apigenin improved the blood lipid metabolism of the hyper-lipidemia model mice. Body weight and serum cholesterol content increased abnormally (P=0.003) as a consequence of high-fat diet. Apigenin increased the activity of superoxide dismutase in EA.hy926 cells (P=0.043) and increased the amount of nitric oxide secreted by the cells (P=0.038). Apigenin also inhibited the proliferation of vascular smooth muscle cells in a dose-dependent manner (P=0.036). In conclusion, apigenin can regulate cholesterol metabolism in vivo and plays a role in reducing the level of blood fat by promoting cholesterol absorption and conversion, and accelerating reverse cholesterol transport. Apigenin also has a role in resisting oxidization and protecting blood vessels.

Apigenin protects endothelium-dependent relaxation of rat aorta against oxidative stress.

Protective Effect of Apigenin on Neurons Against Oxygen‐glucose Deprivation/reperfusion Induced Injury

The Neuroprotective Effect of Apigenin Against OGD/R Injury in Rat Hippocampal Neurons

Inhibition of Superoxide Anion-Mediated Impairment of Endothelium by Treatment with Luteolin and Apigenin in Rat Mesenteric Artery.

[Betulinic Acid Ameliorates Impairment of Endothelium-Dependent Relaxation Induced by Oxidative Stress in Rat Aorta].

Endothelium-dependent Vasorelaxant and Antiproliferative Effects of Apigenin.

Puerarin Protects High Glucose-Induced Injury of Vascular Relaxation by Activation of Heme Oxygenase-1

Apocynin Attenuates Cerebral Infarction after Transient Focal Ischaemia in Rats

Luteolin Improves Vasorelaxation In Aorta Exposed To High Glucose Via Nos-No Pathway

[Nitric Oxide/heme Oxygenase-1 Mediates the Antioxidant Effect of ACEI in Rat Aortic Rings].

Effect of Humulus Flavonoids on High Glucose Induced Dysfunction in Aortic Rings of Rats

Puerarin protects against high glucose-induced acute vascular dysfunction: Role of heme oxygenase-1 in rat thoracic aorta

Nitric Oxide and Small and Intermediate Calcium-Activated Potassium Channels Mediate the Vasodilation Induced by Apigenin in the Resistance Vessels of Hypertensive Rats

Apigenin alleviates oxidative stress-induced myocardial injury by regulating SIRT1 signaling pathway

Apigenin in the regulation of cholesterol metabolism and protection of blood vessels

Apigenin-7- O-β-d-(6″- p-coumaroyl)-glucopyranoside reduces myocardial ischaemia/reperfusion injury in an experimental model via regulating the inflammation response

Apigenin Protects Myocardium by Inhibiting the TGF-β1-mediated Smad Signaling Transduction Pathway in Acute Myocardial Infarcted Rats

Apigenin protects against ischemic stroke by increasing DNA repair

Apelin activates l-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas

Luteolin Reduces High Glucose-Mediated Impairment of Endothelium-Dependent Relaxation in Rat Aorta by Reducing Oxidative Stress.

Apigenin Mediated Protection of Ogd-Evoked Neuron-Like Injury in Differentiated Pc12 Cells